To approach this hypothesis, we combined the ionwas decreased by SCH23390. Furthermore, for neurons that were tophoretic application of selective dopamine antagonists affected by SCH23390, the percent decrease in delay-period activ-(SCH23390 for D1 receptors and sulpiride for D2 receptors) ity was significantly greater than the percent change in background with single-neuron recording in the PM while monkeys peractivity. In more than one-half of the neurons (n Å 26/44, 59%), formed a delayed-reaching (DR) task. The PM is involved background activity was either increased (n Å 10) or not affected in controlling reaching movements with the arms (Cram-(n Å 16) by SCH23390, even though it significantly attenuated mond and Kalaska 1994; Moll and Kuypers 1977; Weinrich delay-period activity. These findings suggest that the activation of and Wise 1982; Weinrich et al. 1984) , and the DR task D1-dopamine receptors plays a modulatory role in PM function in requires such movement based on a visuospatial cue that has preparing for reaching movements.
been presented before a brief delay period. Therefore this task was considered to be adequate for assessing the im-I N T R O D U C T I O N portant function of the PM, i.e., preparation of reaching movements based on visuospatial information. We found a It is well known that the premotor cortex (PM) of primates considerable number of neurons that showed a sustained is involved in motor-set/preparation for forthcoming fore-increase in activity, i.e., set-related activity, during the delay limb movements based on sensory information (for reviews period between a visual instruction signal and a go signal see Kurata 1994; Wise 1985) . For example, a subset of for the execution of reaching movements. We focused here neurons in the monkey PM shows a sustained increase in on this delay-period activity and found that it was preferenactivity during the delay period between a visual instruction tially attenuated by iontophoretic application of a D1-dopasignal and a ''go'' signal for movement execution in a vari-mine receptor antagonist. Our data strongly suggest that the ety of visually guided delayed-movement tasks with the fore-activation of D1-dopamine receptors plays a modulatory role limbs (e.g., Crammond and Kalaska 1994; Kurata 1993; in PM functions in preparing for reaching movements. A Weinrich and Wise 1982; Weinrich et al. 1984) . Such activ-preliminary report of this study has appeared previously (Saity has been designated ''set-related activity'' and is consid-waguchi et al. 1993) . ered to represent a central process in preparing for forthcoming forelimb movements (Kurata 1994; Wise 1985) . How-
ever, the neurochemical basis of the PM function in preparing for forelimb movements is almost completely unTwo rhesus monkeys (Macaca mulatta, males, 3.5-4.5 kg) were known. Recent evidence has suggested that dopamine in trained to perform a DR task. Throughout the experiment, the subjects were treated in accordance with the Guide for Care and frontal motor cortices, including the PM, might play a role Use of Laboratory Animals (National Institutes of Health) and the compared with that during the waiting (control) period. When the discharge rate of a neuron during the warning, cue, delay, and/or Guide for Care and Use of Laboratory Primates (Primate Research Institute, Kyoto University, Aichi, Japan). Each monkey was go period(s) differed significantly from that during the waiting (control) period (Mann-Whitney U test, P õ 0.05), the activity seated in a monkey chair and faced a 21-in. cathode ray tube monitor (CRT) that was positioned Ç40 cm from the monkey's of the neuron was judged to be related to task performance. Among the task-related neurons, those that showed a sustained increase in eyes. Below the CRT, and Ç25 cm from the monkey, three target levers (left, upper, and right) were mounted on a panel. The left activity during the delay period (''delay-period activity'') were examined in the present study. When a neuron's discharge rates and right levers were 20 cm apart and located at shoulder level. The upper lever was located at nose level 10 cm from the left or during both the early and latter halves (2 s, respectively) of the delay period were significantly higher than the discharge rate durright lever. Below the panel, and 10 cm from it, a hold lever was located at waist level. The DR task was initiated when the monkey ing the waiting (control) period (P õ 0.05), it was considered to show delay-period activity. pressed the central hold lever with its left hand. After a 1-s waiting period, a warning cue (green square, 2Њ 1 2Њ) appeared at the When neuronal activity related to the task was encountered during penetration of the micropipette, it was recorded for ú15 succescenter of the CRT (warning period). One-half second later, one of three visual target cues (left, upper, or right; green square, sive trials. Each of the drugs was then applied with a current of 30-100 nA for ú15 successive trials (i.e., more than Ç2 min) to 2Њ 1 2Њ) appeared for 0.5 s (cue period) and was followed by a delay period. The delay period lasted for 4 s, and the color of the examine the effect of the drug on task-related neuronal activity.
When the discharge rate of a neuron changed significantly during central cue changed from green to red, signaling ''go.'' Within 1.2 s after the go signal, the monkey released the hold lever to reach the application of a drug ( P õ 0.05), the neuron was judged to be responsive to the drug. This test was performed using Student's to the target lever above which the cue had been presented (go period). A correct response on a target lever was rewarded by a t-test; when there was a significant difference in variance, the Aspin-Welch method was used for correction. The comparison in drop of water 0.2 s after the response.
activity for predrug trials and trials during drug application was After the training was complete, surgery for the experiment was based on overall activities during all of the periods of the task, and performed under aseptic conditions by a standard method that has when the neuron was found to be significantly affected by the drug, been described previously (Sawaguchi 1987; the activities during each of the task periods were compared by 1990a). Briefly, each monkey was anesthetized with pentobarbital the statistical methods mentioned above. The intensity of the cursodium (20-30 mg/kg ip or iv), and two stainless steel tubes (8 rent used to apply the drugs was usually 50 nA because previous mm ID) were implanted on the anterior and posterior portions of studies showed that a current of 50 nA induced responses of frontal the skull with dental acrylic for head fixation during recording cortical neurons to drugs such as noradrenaline, dopamine, acetylsessions. To prevent bacterial infections, prophylactic antibiotics choline, and dopamine antagonists (Sawaguchi 1987 ; Sawaguchi were injected intramuscularly on the day of the surgery and daily and Matsumura 1985; Sawaguchi et al. 1990a,b) , and this current for 1 wk after surgery. A few weeks after the surgery, the monkeys intensity was sufficient to induce responses in most of the neurons began retrainining for 1-2 wk. As in the experimental sessions, that responded to the drugs. Drug applications were separated by the head of the monkey was rigidly fixed to a stereotaxic frame ú2 min to allow for the recovery of neuronal activity. To prevent on the top of the monkey chair by two stainless steel bars (8 mm leakage of the drugs, a backing current (2-5 nA) was continuously diam). Under this condition, the monkeys performed the DR task applied, during the predrug control period and between drug applifor 500-1,500 trials at a correct-response rate of almost 100% cations, through the tip of each barrel containing drug solution. during both the training and experimental sessions. The mean reacThe areas examined, i.e., PM areas, were estimated physiologition time from the onset of the go signal to movement onset was cally using conventional intracortical microstimulation (ICMS; a Ç310 -380 ms, and the mean movement time, from movement train of 11 0.2-ms cathodal pulses at 333 Hz) (cf., Asanuma 1975) onset to reaching to one of the three target locations (left, upper, during each of the recording sessions. When ICMS ( õ40 mA) at or right), was Ç340 -360 ms.
a cortical site induced a muscle twitch or movement, the site was While the monkeys were performing the DR task, the extracelluconsidered to be located within the motor cortex, and data obtained lar activity of single neurons was recorded from the PM contralatat these sites were excluded from the present examination. The eral to the hand used for DR performance, and drugs were applied PM was defined as the rostral portion of the area in which ICMS iontophoretically to each neuron to examine their effects on neuat an intensity of õ40 mA did not induce muscle twitch or moveronal activity related to DR performance. The iontophoretic techment. These areas and their boundaries were later confirmed by nique and the method used to analyze neuronal activity were similar histological examination based on cytoarchitectonic characteristics, to those described in our previous studies (Sawaguchi 1987; Sawaas described below. guchi et al. 1990a) . Briefly, multibarreled glass micropipettes were After extensive testing, the monkeys were deeply anesthetized used for extracellular recording of neuronal activity and iontophowith an overdose of pentobarbital sodium and perfused with physiretic application of drugs. The central barrel of the micropipette, ological saline followed by formalin. The cortical surface was exwhich contained a carbon-fiber filament (7 mm diam) and was amined to detect the points of penetration. The brains were photofilled with 0.9% saline, was used to record neuronal activity. The graphed, and the frontal lobes were cut serially and coronally at a surrounding barrels were filled with, and used for iontophoretic thickness of 50 mm. The sections were stained by the Nissl method, application of, solutions of the following drugs: SCH23390 (0.01 and cortical layers and areas were determined cytoarchitecturally M, pH 5-6; Research Biochemicals International, Natick, MA); (Barbas and Pandya 1987; He et al. 1993 ; Watanabe-Sawaguchi L -sulpiride (0.01 M, pH 7-8; Research Biochemicals Internaet al. 1991) . Figure 1 illustrates the points of penetration (n Å 36) tional); SCH23388 (0.01 M, pH 5-6; Research Biochemicals Inon the cortical surface of each of the monkeys. As shown in Fig.  ternational) ; and 0.9% saline (to balance the current). The activity 1, the points were distributed in the dorsal and ventral aspects of of a single neuron related to the DR task was recorded by the the PM, i.e., PMd and PMv (He et al. 1993) , and most of the micropipette and converted from A/D by a window discriminator points (31/36, 86%) were distributed in the dorsal PM (i.e., PMd). (DIS-1, BAK Electronics, Germantown, MD) for analysis with a personal computer (PC9801BX, NEC, Tokyo). Raster displays of 50 nA. This neuron showed delay-period activity, particularly for upper trials, and also showed an increase in activity during the warning period. Iontophoretic application of SCH23390 significantly decreased the activity of this neuron (11.0 { 10.4 vs. 7.8 { 9.0 spikes/s, mean { SD; t-test, P õ 0.001). SCH23390 had a significant negative effect on delay-period activity (12.4 { 10.5 vs. 7.0 { 6.5 spikes/s, P õ 0.001), particularly in upper trials (25.7 { 6.4 vs. 14.1 { 5.3 spikes/s, P õ 0.001). The background activity during the waiting period and activity during the warning period were not significantly decreased by SCH23390 (3.1 { 2.6 vs. 3.6 { 3.4 spikes/s, P Å 0.34, NS, for background activity; 24.3 { 9.4 vs. 28.9 { 10.8 spikes/s, P Å 0.09, NS, for the warning period). In contrast to SCH23390, application of sulpiride did not have any clear effect on overall activity (11.0 { 10.4 vs. 10.6 { 11.0 spikes/s, P Å 0.589, NS) or delay-period activity for left, upper, and right trials (6.3 { 3.1 vs. 5.9 { 3.6 spikes/s, P Å 0.347, NS, for left trials; 25.7 { 6.4 vs. 26.8 { 5.6 spikes/s, P Å 0.267, NS, for upper trials; 5.1 { 3.6 vs. 4.2 { 2.9 spikes/s, P Å 0.069, NS, for right trials). As with sulpiride, iontophoretic application of SCH23388 did not affect the activity of most of the neurons tested, the activities of which were signifi-FIG . 1. Points of penetration of the micropipette on the surface of the cantly decreased by SCH23390, as shown in the example in frontal cortex of each of the monkeys. CS, central sulcus; AS, arcuate Fig. 3 . The neuron in Fig. 3 showed delay-period activity, sulcus; PS, principal sulcus; SPcS, superior precentral sulcus. Dashed line particularly for upper and right trials, and also showed an indicates the boundary between the motor cortex and the premotor cortex increase in activity during the cue period. Again, iontopho-(PM), which was determined by intracortical microstimulation (ICMS) and cytoarchitectural characteristics. retic application of SCH23390 significantly decreased the activity of this neuron (7.4 { 4.9 vs. 3.2 { 3.1 spikes/s, P õ 0.001). The delay-period activity was greatly decreased a sustained increase in activity during the delay period, (7.7 { 4.5 vs. 3.3 { 2.9 spikes/s, P õ 0.001), and the i.e., delay-period activity. Iontophoretic application of background activity and activity during the cue period were SCH23390 (usually with a current of 50 nA) significantly less strongly, but still significantly, decreased (3.4 { 2.9 vs. decreased the activity of most of these neurons (n Å 44/56, 2.2 { 2.3 spikes/s, P õ 0.05, for background activity; 79%). In contrast, application of sulpiride or SCH23388 (an 11.0 { 5.8 vs. 6.3 { 5.3 spikes/s, P õ 0.01, for the cue inactive analogue of SCH23399), using the same current period). In contrast to SCH23390, application of SCH23388 intensity, had no effect on the activity of most of the neurons did not have any clear effect on the overall activity (7.4 { tested with these drugs (n Å 31/35 and n Å 21/23, respec-4.9 vs. 7.5 { 5.0 spikes/s, P Å 0.636, NS) or the delaytively), despite the fact that their activity was decreased by period activity (7.7 { 4.5 vs. 7.8 { 4.6 spikes/s, P Å 0.827, SCH23390. NS). Thus SCH23390, but not sulpiride or SCH23388, had Figure 2 shows raster displays and averaged histograms a significant attenuating effect on delay-period activity. for the activity of a PM neuron before (control) and during the application of SCH23390 and sulpiride with a current To further examine the characteristics of the effect of FIG. 2. Effects of iontophoretic application of SCH23390 and sulpiride on a PM neuron with delayperiod activity. Raster displays and averaged histograms, which are aligned by the events that comprise the task, for the activity before (control) and during drug application. W, warning period; C, cue period; D, delay period; GS, onset of the go signal. The activities associated with different target locations (left, upper, and right) are illustrated separately. The drugs were applied to the neuron iontophoretically with a current of 50 nA.
J042-7 / 9k1d$$oc32 09-04-97 16:07:13 neupa LP-Neurophys FIG. 3. Effects of iontophoretic application of SCH23390 and SCH23388 on a PM neuron with delayperiod activity. Conventions are as in Fig. 2. SCH23390 on delay-period activity, we compared the per-a high level of D1 receptors, but a relatively low or negligible level of D2, and probably also D3, receptors (Camps et al. cent changes in the discharge rate during the delay period (relative to predrug control activity) during SCH23390 ap-1989; Cortes et al. 1989; Goldman-Rakic et al. 1990; Lidow et al. 1989; Rischfield et al. 1989 ). Together, these findings plication with the changes in the background activity for each neuron (n Å 44) whose activity was significantly de-suggest that the activation of D1-dopamine receptors is involved in the delay-period activity of PM neurons during creased by the iontophoretic (50 nA) application of SCH23390. In Fig. 4A , the percent changes in the discharge DR task performance.
The present study focused on neurons with delay-period rates during the delay period are plotted against the percent changes in the background activity for the neurons affected activity; i.e., neurons that showed a sustained increase in activity during the delay period between the visual instrucby SCH23390. Most of the data points fall below the 45Њ line, indicating that the application of SCH23390 had a greater tion signal and the go signal for movement execution. Similar sustained activity during such a delay period has been attenuating effect on delay-period activity than on background activity. In more than one-half of the neurons (n Å demonstrated for PM neurons in previous single-neuron studies using monkeys that performed behavioral tasks simi-26/44, 59%), background activity was either increased (n Å 10) or not affected (n Å 16) by SCH23390, even lar to the present DR task, and has been designated ''setrelated activity'' (Crammond and Kalaska 1994; Kurata though it significantly decreased delay-period activity. On average, the percent decrease in delay-period activity was 1993; Weinrich and Wise 1982; Weinrich et al. 1984) . Setrelated activity is considered to play a central role in preparsignificantly greater than the percent change in background activity (mean { SD, 035.5 { 20.7% vs. 07.1 { 24.3%, ing for forelimb movements based on visuospatial information (for reviews, see Kurata 1994; Wise 1985) . The present paired t-test, P õ 0.001), as shown in Fig. 4B . Thus SCH23390 had a greater attenuating effect on delay-period study demonstrated that iontophoretic application of SCH23390 attenuated delay-period activity in most of the activity than on background activity. neurons tested. The percent decrease in delay-period activity was significantly greater than the percent change in back-D I S C U S S I O N ground activity, and, in more than one-half of the neurons, In the present study, the dopamine antagonists SCH23390 SCH23390 significantly decreased the delay-period activity and sulpiride were applied iontophoretically to neurons in but not the background activity. This suggests that the activathe monkey PM, which showed a sustained increase in activ-tion of D1-dopamine receptors plays a modulatory role in ity during the delay period (delay-period activity) in a DR neuronal functions of the PM in preparing for reaching task. Iontophoretic application of SCH23390 significantly movements. decreased the activity of most of these neurons. In contrast, It has been shown in vitro that D1-dopamine receptors the application of sulpiride did not have any clear effect on modulate the synaptic transmission of the excitatory amino the activity of most of the neurons tested with this drug, acid glutamate in the frontal cortex of rats (Lawtho et al. despite the fact that their activity was decreased by 1994). Furthermore, D1-dopamine receptors form asymmet-SCH23390. In addition, an inactive analogue of SCH23390, ric synapses with dendritic spines of pyramidal neurons in SCH23388, had no effect on most of the neurons tested, the primate cerebral cortex (Goldman-Rakic et al. 1989 ; indicating that the effect of SCH23390 was not due to any Smiley and Goldman-Rakic 1993; Smiley et al. 1994) , nonspecific effects, such as a local anesthetic effect. which also suggests that D1-dopamine receptors modulate SCH23390 is a highly selective antagonist of D1-dopamine excitatory neurotransmission, probably glutaminergic transreceptors, whereas sulpiride is a selective antagonist of D2 mission. Moreover, it has been recently demonstrated in rats receptors, which also has a potent affinity for D3 receptors that the activation of D1-dopamine receptors modulates den- (Christensen et al. 1984; Hyttel 1983; Memo et al. 1986 ; dritic-somatic signal integration of pyramidal neurons of the frontal cortex; activation of D1-dopamine receptors restricts Sokoloff et al. 1990 ). The frontal cortex of primates contains ces in primates (Gaspar et al. 1992) . Furthermore, the concentration of dopamine and its metabolites has been shown to be reduced in the frontal cortex of Parkinson's patients (Scatton et al. 1983 ). Based on these previous and the present findings, it is plausible that the dysfunction of D1-dopamine receptors in the PM, and probably also in other frontal motor cortical areas, may contribute to some symptoms, such as bradykinesia, in Parkinson's disease. This possibility is worth considering for the development of improved therapeutic approaches to this disease.
